申请人:Bruce Ian
公开号:US20100093690A1
公开(公告)日:2010-04-15
Compounds of formula I
in free or salt form, wherein R
1
, R
2
, R
3
, R
4
and R
5
have the meanings as indicated in the specification, are useful for treating diseases mediated by phosphatidylinositol 3-kinase. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
式I的化合物,无论是自由形式还是盐形式,其中R1、R2、R3、R4和R5的含义如规范中所示,对于治疗由磷脂酰肌醇3-激酶介导的疾病是有用的。还描述了含有这些化合物的制药组合物以及制备这些化合物的过程。